| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |